| Bacteria meet graphene: modulation of graphene oxide nanosheet interaction with human pathogens for effective antimicrobial therapy V Palmieri, F Bugli, MC Lauriola, M Cacaci, R Torelli, G Ciasca, C Conti, ... ACS Biomaterials Science & Engineering 3 (4), 619-627, 2017 | 126 | 2017 |
| Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents A Brai, R Fazi, C Tintori, C Zamperini, F Bugli, M Sanguinetti, E Stigliano, ... Proceedings of the National Academy of Sciences 113 (19), 5388-5393, 2016 | 117 | 2016 |
| Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients F Paroni Sterbini, A Palladini, L Masucci, CV Cannistraci, R Pastorino, ... Applied and environmental microbiology 82 (22), 6633-6644, 2016 | 112 | 2016 |
| Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008 L Masucci, R Graffeo, S Bani, F Bugli, S Boccia, N Nicolotti, B Fiori, ... Eurosurveillance 16 (24), 19891, 2011 | 106 | 2011 |
| Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells M Papi, D Caputo, V Palmieri, R Coppola, S Palchetti, F Bugli, C Martini, ... Nanoscale 9 (29), 10327-10334, 2017 | 96 | 2017 |
| Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments R Burioni, P Plaisant, A Manzin, D Rosa, VD Carri, F Bugli, L Solforosi, ... Hepatology 28 (3), 810-814, 1998 | 96 | 1998 |
| Nanomedicine approaches for the pulmonary treatment of cystic fibrosis C Velino, F Carella, A Adamiano, M Sanguinetti, A Vitali, D Catalucci, ... Frontiers in Bioengineering and Biotechnology 7, 406, 2019 | 77 | 2019 |
| Human monoclonal antibody‐based therapy in the treatment of invasive candidiasis F Bugli, M Cacaci, C Martini, R Torelli, B Posteraro, M Sanguinetti, ... Journal of Immunology Research 2013 (1), 403121, 2013 | 76 | 2013 |
| Curcumin-loaded graphene oxide flakes as an effective antibacterial system against methicillin-resistant Staphylococcus aureus F Bugli, M Cacaci, V Palmieri, R Di Santo, R Torelli, G Ciasca, M Di Vito, ... Interface focus 8 (3), 20170059, 2018 | 71 | 2018 |
| Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries F Bugli, N Mancini, CY Kang, C Di Campli, A Grieco, A Manzin, A Gabrielli, ... Journal of Virology 75 (20), 9986-9990, 2001 | 71 | 2001 |
| Biomimetic antimicrobial cloak by graphene-oxide agar hydrogel M Papi, V Palmieri, F Bugli, M De Spirito, M Sanguinetti, C Ciancico, ... Scientific reports 6 (1), 12, 2016 | 63 | 2016 |
| Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites V Palmieri, F Bugli, M Cacaci, G Perini, FD Maio, G Delogu, R Torelli, ... Nanomedicine 13 (22), 2867-2879, 2018 | 60 | 2018 |
| Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs R Burioni, F Bugli, N Mancini, D Rosa, C Di Campli, G Moroncini, ... Virology 288 (1), 29-35, 2001 | 55 | 2001 |
| In Vitro Interaction between Alginate Lyase and Amphotericin B against Aspergillus fumigatus Biofilm Determined by Different Methods F Bugli, B Posteraro, M Papi, R Torelli, A Maiorana, F Paroni Sterbini, ... Antimicrobial Agents and Chemotherapy 57 (3), 1275-1282, 2013 | 52 | 2013 |
| A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor AL Fallacara, C Zamperini, A Podolski-Renić, J Dinić, T Stanković, ... Cancers 11 (6), 848, 2019 | 42 | 2019 |
| The PavA-like Fibronectin-Binding Protein of Enterococcus faecalis, EfbA, Is Important for Virulence in a Mouse Model of Ascending Urinary Tract Infection R Torelli, P Serror, F Bugli, FP Sterbini, AR Florio, A Stringaro, M Colone, ... The Journal of infectious diseases 206 (6), 952-960, 2012 | 42 | 2012 |
| Graphene oxide coatings as tools to prevent microbial biofilm formation on medical device M Cacaci, C Martini, C Guarino, R Torelli, F Bugli, M Sanguinetti Advances in Microbiology, Infectious Diseases and Public Health: Volume 14 …, 2020 | 41 | 2020 |
| Reduction and shaping of graphene-oxide by laser-printing for controlled bone tissue regeneration and bacterial killing V Palmieri, M Barba, L Di Pietro, S Gentilini, MC Braidotti, C Ciancico, ... 2D Materials 5 (1), 015027, 2017 | 40 | 2017 |
| In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm F Bugli, V Palmieri, R Torelli, M Papi, M De Spirito, M Cacaci, S Galgano, ... Biotechnology Progress 32 (6), 1584-1591, 2016 | 40 | 2016 |
| Is the antimicrobial activity of hydrolates lower than that of essential oils? M Di Vito, A Smolka, MR Proto, L Barbanti, F Gelmini, E Napoli, ... Antibiotics 10 (1), 88, 2021 | 38 | 2021 |
